美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Latigo Biotherapeutics Inc

23.93

+0.87003.77%

盤後：24.350.4200+1.76%17:30 EDT

成交量：43.10萬

成交額：1,033.69萬

市值：15.87億

市盈率：-14.28

高：24.80

開：23.14

低：23.09

收：23.06

52周最高：25.93

52周最低：17.22

股本：6,629.93萬

流通股本：2,212.13萬

量比：1.82

換手率：1.95%

股息：- -

股息率：- -

每股收益(TTM):-1.6760

每股收益(LYR):-129.2325

淨資產收益率：--

總資產收益率：--

市淨率：-5.75

市盈率(LYR):-0.19

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Leerink Partners首次覆蓋Latigo Biotherapeutics，給予「跑贏大盤」評級，目標價36美元

美股異動 | Latigo Biotherapeutics(LTGO.US)登陸美股市場開盤後股價升逾14%

異動解讀 | Latigo Biotherapeutics首日上市盤中大漲16.67%，生物科技IPO熱潮與創新管線獲市場追捧

Latigo在將IPO規模擴大至3.456億美元后，即將於納斯達克首日上市，開盤有望走高

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/LTGO"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LTGO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","market":"US","secType":"STK","nameCN":"Latigo Biotherapeutics Inc","latestPrice":23.93,"timestamp":1789675200000,"preClose":23.06,"halted":0,"volume":431019,"hourTrading":{"tag":"盘后","latestPrice":24.35,"preClose":23.93,"latestTime":"17:30 EDT","volume":20290,"amount":485581.70029999997,"timestamp":1789680653796,"change":0.42,"changeRate":0.017551,"amplitude":0.017551},"delay":0,"changeRate":0.03772766695576761,"floatShares":22121291,"shares":66299347,"eps":-1.676,"marketStatus":"盤後交易","change":0.87,"latestTime":"09-17 18:31:55 EDT","open":23.14,"high":24.8,"low":23.085,"amount":10336947.64902,"amplitude":0.074371,"askPrice":24.4,"askSize":81,"bidPrice":23.46,"bidSize":86,"shortable":3,"etf":0,"ttmEps":-1.676,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":23.06,"postHourTrading":{"tag":"盘后","latestPrice":24.35,"preClose":23.93,"latestTime":"17:30 EDT","volume":20290,"amount":485581.70029999997,"timestamp":1789680653796,"change":0.42,"changeRate":0.017551,"amplitude":0.017551},"volumeRatio":1.823834},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","floatShares":22121291,"roa":"--","roe":"--","lyrEps":-129.23255,"volumeRatio":1.823834,"shares":66299347,"dividePrice":0,"high":24.8,"amplitude":0.074371,"preClose":23.06,"low":23.085,"week52Low":17.2201,"pbRate":"-5.75","week52High":25.93,"institutionHeld":0,"latestPrice":23.93,"committee":0.02994,"eps":-1.676,"divideRate":0,"volume":431019,"delay":0,"ttmEps":-1.676,"open":23.14,"prevYearClose":18,"prevWeekClose":22.15,"prevMonthClose":22.02,"prevQuarterClose":18,"fiveDayClose":21.54,"twentyDayClose":20.94,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTGO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTGO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LTGO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1788580800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LTGO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LTGO","date":"2026-09-16","current":-14.278043,"percent":0.148148,"low":-14.220252,"twenty":-13.675766,"median":-12.593455,"eighty":-11.046861,"high":-10.257227,"avg":-12.3801,"sd":1.213178,"marketCap":1525547974},"quantilePoints":[{"date":"2026-08-07","current":-10.257227,"twenty":-10.257227,"median":-10.257227,"eighty":-10.257227,"marketCap":1140357438},{"date":"2026-08-14","current":-11.41033,"twenty":-11.020695,"median":-10.545739,"eighty":-10.380784,"marketCap":1268554881},{"date":"2026-08-21","current":-12.172536,"twenty":-11.41033,"median":-11.020695,"eighty":-10.534363,"marketCap":1353293842},{"date":"2026-08-28","current":-14.220252,"twenty":-12.724282,"median":-11.393266,"eighty":-10.557115,"marketCap":1580950750},{"date":"2026-09-04","current":-12.786851,"twenty":-12.786851,"median":-12.172536,"eighty":-10.978035,"marketCap":1421590914},{"date":"2026-09-11","current":-12.849682,"twenty":-13.626145,"median":-12.513822,"eighty":-11.012163,"marketCap":1428087934},{"date":"2026-09-16","current":-13.72661,"twenty":-13.675766,"median":-12.593455,"eighty":-11.046861,"marketCap":1525547974}],"updateTime":1789684315936},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LTGO\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1194266130","title":"Leerink Partners首次覆蓋Latigo Biotherapeutics，給予「跑贏大盤」評級，目標價36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194266130","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194266130?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 18:06","pubTimestamp":1788257170,"startTime":"0","endTime":"0","summary":"Leerink Partners宣布正式启动对Latigo Biotherapeutics, Inc.（股票代码：LTGO）的研究覆盖。该机构给予该公司“跑赢大盘”评级，并将其目标股价设定为每股36美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTGO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657406616","title":"美股異動 | Latigo Biotherapeutics(LTGO.US)登陸美股市場 開盤後股價升逾14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657406616","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657406616?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 00:17","pubTimestamp":1786119476,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，非阿片止痛药开发商Latigo Biotherapeutics(LTGO.US)登陆美股市场，截至发稿，该股涨超14%，报20.53美元。Latigo致力于开发针对Nav1.8钠离子通道的非阿片类止痛药物。其核心候选药物LTG-001是一款口服Nav1.8抑制剂，主要用于治疗中度至重度急性疼痛，包括术后疼痛。这种药物旨在提供媲美阿片类药物的镇痛效果，同时避免成瘾风险。Nav1.8主要表达于外周疼痛感觉神经元，其抑制剂不作用于中枢神经系统，因此不具备成瘾性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LTGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126044680","title":"異動解讀 | Latigo Biotherapeutics首日上市盤中大漲16.67%，生物科技IPO熱潮與創新管線獲市場追捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1126044680","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126044680?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 23:42","pubTimestamp":1786117348,"startTime":"0","endTime":"0","summary":"生物科技公司Latigo Biotherapeutics今日盘中大涨16.67%，成为市场焦点。该股今日在纳斯达克首日上市，开盘后股价迅速走高，表现强劲。此次股价大涨主要得益于Latigo规模扩大的首次公开募股获得市场热烈响应。此外，公司上市正值生物科技板块IPO的黄金窗口期，2026年以来美国生物科技和制药企业IPO加权平均回报率高达55%，市场对具备差异化临床数据和明确市场机会的平台型公司兴趣浓厚，为Latigo的股价表现提供了有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LTGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657764162","title":"Latigo在將IPO規模擴大至3.456億美元后，即將於納斯達克首日上市，開盤有望走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2657764162","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657764162?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 21:56","pubTimestamp":1786111014,"startTime":"0","endTime":"0","summary":"BUZZ-Latigo在将IPO规模扩大至3.456亿美元后，即将于纳斯达克首日上市，开盘有望走高8月7日-** 药物开发商Latigo Biotherapeutics（LTGO.O）完成3.456亿美元美国IPO后，纳斯达克首日上市开盘价有望高于发行价** 该股最新显示开盘价为每股20美元，高于18美元的发行价** 总部位于加利福尼亚州千橡市的LTGO公司通过规模扩大的首次公开募股，以每股18美","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL4T44415Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","IE00B19Z3581.USD","LU2237443622.USD","LU2750360997.AUD","LU1791807156.HKD","LU2471134879.HKD","BK4516","LU2237443895.HKD","IE0002270589.USD","LU1868836914.USD","BK4550","LU1894683264.USD","LU1804176565.USD","LU0345770308.USD","LU2471134952.CNY","LU1868836757.USD","BK4552","LU0742534661.SGD","LU1868836591.USD","GSX","LU0061475181.USD","BK4533","LU0251131958.USD","LU0868494708.USD","LU0942090050.USD","BK4207","IE0004091025.USD","LU1868837300.USD","IE0004086264.USD","LU1668664300.SGD","LU2237443382.USD","BK4588","IE00B19Z3B42.SGD","BK4127","LU2237443549.SGD","MNSH","LU0096364046.USD","LU2471134523.USD","LU0106831901.USD","LU1868837136.USD","BK4585","LU0345770993.USD","LU2237443978.SGD","IE00BFXG1179.USD","LU2750360641.GBP","LU2237443465.HKD","LTGO","LU2265009873.SGD","IE0034235188.USD","LU0048573561.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LTGO\",params:#limit:6,delay:false,,,undefined,":[]}}